Role of RDW as Anon Invasive Index for Predicting Liver Cell Failure and Portal Hypertension in Cirrhotic Patient

NCT03242135 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2017-08-08

No results posted yet for this study

Summary

role of RDW as anon invasive method for predicting liver cell failure \& portal hypertension in cirrhotic patient

Conditions

  • Predicting Liver Cell Failure & Portal Hypertension in LC

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • marina Atef, master · Assiut University

Eligibility

Min Age
17 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-21
Primary Completion
2018-02-21
Completion
2018-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03242135 on ClinicalTrials.gov